What are you looking for?

Need help finding what you are looking for? Contact Us

Compare

Free Samples

Home Market Research Reports Pharmaceutical

Generic Drugs Respiratory

PUBLISHER: 360iResearch | PRODUCT CODE: 1293752

PUBLISHER: 360iResearch | PRODUCT CODE: 1293752

Inhalation & Nasal Sprays Generic Drugs Market by Indication, Age Group, Class, Route, Distrubution Channel - Russia Ukraine Conflict and High Inflation - Global Forecast 2023-2030

PUBLISHED: June 12, 2023

PAGES: 196 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The Global Inhalation & Nasal Sprays Generic Drugs Market is forecasted to grow significantly, with a projected USD 8,090.64 million in 2023 at a CAGR of 8.60% and expected to reach a staggering USD 14,432.72 million by 2030.

The the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Inhalation & Nasal Sprays Generic Drugs Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Inhalation & Nasal Sprays Generic Drugs Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Indication, market is studied across Allergic Rhinitis, Asthma, and COPD. The Asthma commanded largest market share of 42.41% in 2022, followed by COPD.

Based on Age Group, market is studied across Adults, Children 2 to 5, and Children 6 to 12. The Adults commanded largest market share of 69.02% in 2022, followed by Children 6 to 12.

Based on Class, market is studied across Allergy Blocker, Anticholinergic, Antihistamine, Decongestant, Mast Cell Inhibitor, and Nasal Steroid. The Anticholinergic commanded largest market share of 22.96% in 2022, followed by Antihistamine.

Based on Route, market is studied across Inhalation, Nasal Spray, and Tropical Lotion. The Inhalation commanded largest market share of 56.04% in 2022, followed by Tropical Lotion.

Based on Distrubution Channel, market is studied across Hospital Medical Store, Online Pharmacy, and Pharmacy Retail. The Pharmacy Retail commanded largest market share of 43.55% in 2022, followed by Hospital Medical Store.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 41.67% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Inhalation & Nasal Sprays Generic Drugs Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Inhalation & Nasal Sprays Generic Drugs Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Inhalation & Nasal Sprays Generic Drugs Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Inhalation & Nasal Sprays Generic Drugs Market?

4. What is the competitive strategic window for opportunities in the Global Inhalation & Nasal Sprays Generic Drugs Market?

5. What are the technology trends and regulatory frameworks in the Global Inhalation & Nasal Sprays Generic Drugs Market?

6. What is the market share of the leading vendors in the Global Inhalation & Nasal Sprays Generic Drugs Market?

7. What modes and strategic moves are considered suitable for entering the Global Inhalation & Nasal Sprays Generic Drugs Market?

Product Code: MRR-032A67D91429

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Inhalation & Nasal Sprays Generic Drugs Market, by Indication, 2022 vs 2030
4.3. Inhalation & Nasal Sprays Generic Drugs Market, by Age Group, 2022 vs 2030
4.4. Inhalation & Nasal Sprays Generic Drugs Market, by Class, 2022 vs 2030
4.5. Inhalation & Nasal Sprays Generic Drugs Market, by Route, 2022 vs 2030
4.6. Inhalation & Nasal Sprays Generic Drugs Market, by Distrubution Channel, 2022 vs 2030
4.7. Inhalation & Nasal Sprays Generic Drugs Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Low Cost Involved with Generic Prescription Drugs
  - 5.1.1.2. Increasing Prevalence of Respiratory Diseases
  - 5.1.1.3. Significant Adoption of Nebulizers for Children
- 5.1.2. Restraints
  - 5.1.2.1. Stringent Regulations For Generic Drugs
- 5.1.3. Opportunities
  - 5.1.3.1. Patent Expiry of Blockbuster Drugs and Increasing FDA Approvals
  - 5.1.3.2. Growing Investments from Pharmaceutical Companies for R&D
- 5.1.4. Challenges
  - 5.1.4.1. Pricing Pressure due to Presence of Multiple Players in the Segment
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization
- 5.9.1. Changing Formulation & Delivery Device

6. Inhalation & Nasal Sprays Generic Drugs Market, by Indication

6.1. Introduction
6.2. Allergic Rhinitis
6.3. Asthma
6.4. COPD

7. Inhalation & Nasal Sprays Generic Drugs Market, by Age Group

7.1. Introduction
7.2. Adults
7.3. Children 2 to 5
7.4. Children 6 to 12

8. Inhalation & Nasal Sprays Generic Drugs Market, by Class

8.1. Introduction
8.2. Allergy Blocker
8.3. Anticholinergic
8.4. Antihistamine
8.5. Decongestant
8.6. Mast Cell Inhibitor
8.7. Nasal Steroid

9. Inhalation & Nasal Sprays Generic Drugs Market, by Route

9.1. Introduction
9.2. Inhalation
9.3. Nasal Spray
9.4. Tropical Lotion

10. Inhalation & Nasal Sprays Generic Drugs Market, by Distrubution Channel

10.1. Introduction
10.2. Hospital Medical Store
10.3. Online Pharmacy
10.4. Pharmacy Retail

11. Americas Inhalation & Nasal Sprays Generic Drugs Market

11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States

12. Asia-Pacific Inhalation & Nasal Sprays Generic Drugs Market

12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
12.13. Vietnam

13. Europe, Middle East & Africa Inhalation & Nasal Sprays Generic Drugs Market

13.1. Introduction
13.2. Denmark
13.3. Egypt
13.4. Finland
13.5. France
13.6. Germany
13.7. Israel
13.8. Italy
13.9. Netherlands
13.10. Nigeria
13.11. Norway
13.12. Poland
13.13. Qatar
13.14. Russia
13.15. Saudi Arabia
13.16. South Africa
13.17. Spain
13.18. Sweden
13.19. Switzerland
13.20. Turkey
13.21. United Arab Emirates
13.22. United Kingdom

14. Competitive Landscape

14.1. FPNV Positioning Matrix
14.2. Market Share Analysis, By Key Player
14.3. Competitive Scenario Analysis, By Key Player

15. List of Company Mentioned

16. Appendix

16.1. Discussion Guide
16.2. License & Pricing

1. AbbVie Inc.

2. Akorn, Inc.

3. Altaire Pharmaceuticals Inc.

4. Apotex Inc.

5. AstraZeneca PLC

6. Beximco Pharmaceuticals Ltd.

7. Catalent Pharma Solutions, Inc.

8. Chiesi Farmaceutici S.p.A.

9. Cipla Limited

10. Hikma Pharmaceuticals PLC

11. Nephron Pharmaceuticals Corporation

12. Perrigo Company PLC

13. Preferred Pharmaceuticals, Inc.

14. Sandoz International GmbH

15. Sheffield Pharmaceuticals, LLC

16. Sun Pharmaceutical Industries Ltd.

17. Teva Pharmaceutical Industries Ltd.

18. Viatris Inc.